Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 9631510, 13 pages
http://dx.doi.org/10.1155/2016/9631510
Research Article

Interleukin-29 Enhances Synovial Inflammation and Cartilage Degradation in Osteoarthritis

1Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
2Department of Traditional Chinese Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
3Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
4Sutton Arthritis Research Laboratories, University of Sydney at Royal North Shore Hospital, Sydney, NSW, Australia

Received 8 April 2016; Revised 23 May 2016; Accepted 29 May 2016

Academic Editor: Anshu Agrawal

Copyright © 2016 Lingxiao Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Wang, L. Xu, X. Feng, D. Guo, W. Tan, and M. Zhang, “Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis,” Arthritis Research and Therapy, vol. 14, no. 5, article R228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Xu, X. Feng, W. Tan et al., “IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients,” Arthritis Research & Therapy, vol. 15, no. 5, article R170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. N. J. Megjugorac, G. E. Gallagher, and G. Gallagher, “Modulation of human plasmacytoid DC function by IFN-λ1 (IL-29),” Journal of Leukocyte Biology, vol. 86, no. 6, pp. 1359–1363, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. B.-S. Liu, H. L. A. Janssen, and A. Boonstra, “IL-29 and IFNα differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNγ receptor expression,” Blood, vol. 117, no. 8, pp. 2385–2395, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Wolk, K. Witte, E. Witte et al., “IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis,” Science Translational Medicine, vol. 5, no. 204, Article ID 204ra129, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. R. A. de Groen, A. Boltjes, J. Hou et al., “IFN-λ-mediated IL-12 production in macrophages induces IFN-γ production in human NK cells,” European Journal of Immunology, vol. 45, no. 1, pp. 250–259, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. S. V. Kotenko, “IFN-lambdas,” Current Opinion in Immunology, vol. 23, no. 5, pp. 583–590, 2011. View at Google Scholar
  8. M. Li, X. Liu, Y. Zhou, and B. S. Shao, “Interferon-λs: the modulators of antivirus, antitumor, and immune responses,” Journal of Leukocyte Biology, vol. 86, no. 1, pp. 23–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Abushahba, M. Balan, I. Castaneda et al., “Antitumor activity of Type i and Type III interferons in BNL hepatoma model,” Cancer Immunology, Immunotherapy, vol. 59, no. 7, pp. 1059–1071, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S. He, H. Zhang, H. Chen et al., “Expression and release of IL-29 by mast cells and modulation of mast cell behavior by IL-29,” Allergy, vol. 65, no. 10, pp. 1234–1241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. Q. Wu, Q. Yang, E. Lourenco, H. Sun, and Y. Zhang, “Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: Its correlation with disease activity,” Arthritis Research and Therapy, vol. 13, no. 3, article R88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S.-C. Lin, C.-C. Kuo, J.-T. Tsao, and L.-J. Lin, “Profiling the expression of interleukin (IL)-28 and IL-28 receptor α in systemic lupus erythematosus patients,” European Journal of Clinical Investigation, vol. 42, no. 1, pp. 61–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. C. Steenvoorden, R. A. Bank, H. K. Ronday, R. E. M. Toes, T. W. J. Huizinga, and J. DeGroot, “Fibroblast-like synoviocyte-chondrocyte interaction in cartilage degradation,” Clinical and Experimental Rheumatology, vol. 25, no. 2, pp. 239–245, 2007. View at Google Scholar · View at Scopus
  14. A. Nair, V. Kanda, C. Bush-Joseph et al., “Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and toll-like receptor 2 ligands via soluble CD14,” Arthritis & Rheumatism, vol. 64, no. 7, pp. 2268–2277, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. W. J. Jordan, J. Eskdale, M. Boniotto, M. Rodia, D. Kellner, and G. Gallagher, “Modulation of the human cytokine response by interferon lambda-1 (IFN-λ1/IL-29),” Genes and Immunity, vol. 8, no. 1, pp. 13–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. S. R. Pickens, N. D. Chamberlain, M. V. Volin, R. M. Pope, A. M. Mandelin II, and S. Shahrara, “Characterization of CCL19 and CCL21 in rheumatoid arthritis,” Arthritis & Rheumatism, vol. 63, no. 4, pp. 914–922, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Erturk, D. Tastekin, M. Serilmez, E. Bilgin, H. U. Bozbey, and S. Vatansever, “Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer,” Tumor Biology, vol. 37, no. 1, pp. 405–412, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Pekarek, S. Srinivas, J. EskdaleJ, and G. Gallagher, “Interferon lambda-1 (IFN-lambda1/IL-29) induces ELR(−) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner,” Genes and Immunity, vol. 8, no. 2, pp. 177–180, 2007. View at Google Scholar
  19. W. J. Jordan, J. Eskdale, S. Srinivas et al., “Human interferon lambda-1 (IFN-λ1/IL-29) modulates the Th1/Th2 response,” Genes and Immunity, vol. 8, no. 3, pp. 254–261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Dai, N. J. Megjugorac, G. E. Gallagher, R. Y. L. Yu, and G. Gallagher, “IFN-λ1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells,” Blood, vol. 113, no. 23, pp. 5829–5838, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Haseeb and T. M. Haqqi, “Immunopathogenesis of osteoarthritis,” Clinical Immunology, vol. 146, no. 3, pp. 185–196, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. S. He, T. Li, H. Chen et al., “CD14+ cell-derived IL-29 modulates proinflammatory cytokine production in patients with allergic airway inflammation,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 66, no. 2, pp. 238–246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Brand, F. Beigel, T. Olszak et al., “IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 289, no. 5, pp. G960–G968, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Zhou, O. J. Hamming, N. Ank, S. R. Paludan, A. L. Nielsen, and R. Hartmann, “Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases,” Journal of Virology, vol. 81, no. 14, pp. 7749–7758, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. K. D. Guenterberg, V. P. Grignol, E. T. Raig et al., “Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis,” Molecular Cancer Therapeutics, vol. 9, no. 2, pp. 510–520, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Dumoutier, A. Tounsi, T. Michiels, C. Sommereyns, S. V. Kotenko, and J. C. Renauld, “Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling,” The Journal of Biological Chemistry, vol. 279, no. 31, pp. 32269–32274, 2004. View at Google Scholar